896 results match your criteria: "Jichi Medical University Saitama Medical Center.[Affiliation]"
J Stroke Cerebrovasc Dis
November 2024
Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address:
Cancers (Basel)
August 2024
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
Cancers (Basel)
July 2024
Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama 241-8515, Japan.
The development of new treatment strategies to improve the prognosis of mucosal malignant melanoma of the head and neck (MMHN) after carbon ion radiotherapy (CIRT) is essential because of the risk of distant metastases. Therefore, our objective was to evaluate the outcomes of immune checkpoint inhibitor (ICI) treatment to justify its inclusion in the regimen after CIRT. Thirty-four patients who received CIRT as an initial treatment were included in the analysis and stratified into three groups: those who did not receive ICIs (Group A), those who received ICIs after recurrence or metastasis (Group B), and those who received ICIs as adjuvant therapy after CIRT (Group C).
View Article and Find Full Text PDFArch Gerontol Geriatr
December 2024
The Department of Geriatric Medicine, The University of Tokyo, Japan; The Department of Geriatric Medicine, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Japan.
Neurosurgery
August 2024
Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Background And Objectives: Although intraprocedural rupture (IPR) is rare, it is a devastating complication of endovascular treatment (EVT) for intracranial aneurysms. Very few studies have been conducted on IPR, and the safety and efficacy of management techniques of IPR have not been investigated.
Methods: Patients who experienced IPR during EVT between 2013 and 2022 were enrolled from a multicenter observational registry.
Intern Med
August 2024
Division of Rheumatology, First Department of Comprehensive Medicine, Jichi Medical University Saitama Medical Center, Japan.
JA Clin Rep
July 2024
Department of Anesthesiology, Saitama International Medical Center, 1397-1, Yamane, Hidaka-City, Saitama-Pref, 350-1298, Japan.
Eur J Radiol Open
December 2024
Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, N14 W5, Kita-Ku, Sapporo 060-8648, Japan.
Br J Haematol
September 2024
Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Int J Clin Oncol
October 2024
Department of Urology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.
Background: A useful biomarker for the efficacy of immune checkpoint inhibitors (ICIs) in advanced renal cell carcinoma (RCC) has not yet been established. This study aims to investigate whether inflammatory markers are associated with the efficacy of nivolumab plus ipilimumab therapy before and during treatment.
Methods: Data from patients with advanced clear cell RCC who received a combination treatment of nivolumab plus ipilimumab were retrospectively analyzed.
Can J Ophthalmol
December 2024
The University of Tokyo Hospital, Tokyo, Japan; Jichi Medical University Saitama Medical Center, Saitama, Japan.
Clin Neurol Neurosurg
September 2024
Department of Endovascular Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Tokyo, Bunkyo-ku 113-8519, Japan. Electronic address:
J Neurosurg Case Lessons
July 2024
Departments of Neurosurgery, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Gen Thorac Cardiovasc Surg
July 2024
Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847, Amanuma-Cho, Omiya-Ku, Saitama-Shi, Saitama, 330-8503, Japan.
Objective: Systemic heparinization during cardiopulmonary bypass (CPB) can significantly affect thromboelastography (TEG). This study investigated the feasibility of adding protamine in vitro to allow assessment of coagulation status using the TEG 6s system during CPB.
Methods: In this prospective observational study, 21 patients undergoing elective cardiac valve surgery were evaluated.
Cureus
June 2024
Department of Anesthesiology and Critical Care Medicine, Jichi Medical University, Saitama, JPN.
Andexanet alfa neutralizes factor Xa inhibitors in critical bleeding situations. However, in cardiac surgery with cardiopulmonary bypass (CPB), heparin resistance induced by andexanet alfa should be a concern, and the lack of point-of-care monitoring of plasma concentration of factor Xa inhibitors makes it difficult to decide when to administer andexanet alfa. A 69-year-old man underwent emergency surgery for acute pulmonary thromboembolism.
View Article and Find Full Text PDFPancreatology
September 2024
Department of Critical Care Medicine University Hospital, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-City, Fukuoka, 807-0804, Japan.
Blood Adv
August 2024
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Chronic graft-versus-host disease (GVHD) is 1 of the major complications after allogeneic hematopoietic cell transplantation (allo-HCT). Although various risk factors for chronic GVHD have been reported, limited data are available regarding the impact of acute GVHD on chronic GVHD. We examined the association between acute and chronic GVHD using a Japanese registry data set.
View Article and Find Full Text PDFCancer Med
July 2024
Department of Integrative Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Background: Cancer utilizes immunosuppressive mechanisms to create a tumor microenvironment favorable for its progression. The purpose of this study is to histologically characterize the immunological properties of the tumor microenvironment of oral squamous cell carcinoma (OSCC) and identify key molecules involved in the immunological microenvironment and patient prognosis.
Methods: First, overlapping differentially expressed genes (DEGs) were screened from OSCC transcriptome data in public databases.
Cytotherapy
November 2024
Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan. Electronic address:
Background Aims: Pre-transplant lung dysfunction is known to be a risk factor for non-relapse mortality (NRM) after allogeneic hematopoietic cell transplantation (allo-HCT). It is unclear which cell source gives better outcomes for patients with pulmonary dysfunction.
Methods: We analyzed 3289 adult patients with standard-risk disease who had received HLA-matched allo-HCT, and compared outcomes between those who received peripheral blood stem cell (PBSC) vs.
Cardiovasc Diabetol
June 2024
Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death with type 2 diabetes; however, their effect on arrhythmias is unclear. The purpose of this study was to investigate the effects of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes.
Methods: A total of 150 patients with type 2 diabetes who were treated with an implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator (ICD/CRT-D) were randomized to once-daily empagliflozin or placebo for 24 weeks.
Am J Emerg Med
August 2024
Department of Emergency and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-Cho, Omiya-Ku, Saitama-Shi, Saitama, Japan. Electronic address:
Life (Basel)
June 2024
Department of Neurology, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
The misdiagnosis of headache disorders is a serious issue, and AI-based headache model diagnoses with external validation are scarce. We previously developed an artificial intelligence (AI)-based headache diagnosis model using a database of 4000 patients' questionnaires in a headache-specializing clinic and herein performed external validation prospectively. The validation cohort of 59 headache patients was prospectively collected from August 2023 to February 2024 at our or collaborating multicenter institutions.
View Article and Find Full Text PDFJ Infect Chemother
June 2024
Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan. Electronic address:
Haematologica
November 2024
Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama.
JPRAS Open
September 2024
Department of Plastic and Reconstructive Surgery, University of the Ryukyus Hospital, Okinawa, Japan.
Introduction: Restoring oral intake through oropharyngeal reconstruction is vital for patients undergoing total glossolaryngectomy. Despite its importance, research in this area is limited, leaving clinicians with few guidelines. The debate regarding the optimal shape of the reconstructed oropharynx highlights the need for further research.
View Article and Find Full Text PDF